NCT06844383
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06844383
Title A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide (TALENT)
Acronym TALENT
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Prostate Cancer Clinical Trials Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
UCSD Moores Cancer Center RECRUITING La Jolla California 92037 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Masonic Cancer Center RECRUITING Minneapolis Minnesota 55455 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
University of Wisconsin Carbone Cancer Center-Madison RECRUITING Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field